CIT
Basic information
Region (hg38): 12:119685791-119877320
Links
Phenotypes
GenCC
Source:
- microcephaly 17, primary, autosomal recessive (Moderate), mode of inheritance: AR
- autosomal recessive primary microcephaly (Supportive), mode of inheritance: AR
- microcephaly 17, primary, autosomal recessive (Strong), mode of inheritance: AR
- microcephaly 17, primary, autosomal recessive (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Microcephaly 17, primary, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 27453578; 27453579; 27503289; 27519304 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (378 variants)
- Inborn_genetic_diseases (213 variants)
- Microcephaly_17,_primary,_autosomal_recessive (45 variants)
- CIT-related_disorder (45 variants)
- not_specified (26 variants)
- Autosomal_recessive_primary_microcephaly (4 variants)
- Long_QT_syndrome (2 variants)
- Intellectual_disability (2 variants)
- Marfanoid_habitus_and_intellectual_disability (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CIT gene is commonly pathogenic or not. These statistics are base on transcript: NM_001206999.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 114 | 13 | 132 | |||
| missense | 267 | 25 | 300 | |||
| nonsense | 7 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 6 | |||||
| Total | 14 | 8 | 273 | 139 | 15 |
Highest pathogenic variant AF is 0.000024279158
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CIT | protein_coding | protein_coding | ENST00000392521 | 47 | 191501 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 0.000300 | 125701 | 0 | 46 | 125747 | 0.000183 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.82 | 825 | 1.20e+3 | 0.689 | 0.0000743 | 13576 |
| Missense in Polyphen | 234 | 381.37 | 0.61358 | 4263 | ||
| Synonymous | 1.10 | 442 | 472 | 0.936 | 0.0000301 | 3901 |
| Loss of Function | 8.44 | 23 | 125 | 0.185 | 0.00000699 | 1397 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000270 | 0.000270 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000165 | 0.000163 |
| Finnish | 0.0000930 | 0.0000924 |
| European (Non-Finnish) | 0.000266 | 0.000246 |
| Middle Eastern | 0.000165 | 0.000163 |
| South Asian | 0.000167 | 0.000163 |
| Other | 0.000170 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}.;
- Disease
- DISEASE: Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH17 is a severe form characterized by lissencephaly, enlarged ventricles, agenesis of the corpus callosum, cerebellar hypoplasia, and brainstem hypoplasia. Patients manifest delayed psychomotor development, intellectual disability, spasticity, axial hypotonia, and dysmorphic features. {ECO:0000269|PubMed:27453578, ECO:0000269|PubMed:27453579, ECO:0000269|PubMed:27503289, ECO:0000269|PubMed:27519304}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- G13 Signaling Pathway;Signal Transduction;RHO GTPases activate CIT;RHO GTPase Effectors;Signaling by Rho GTPases;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.371
Intolerance Scores
- loftool
- 0.475
- rvis_EVS
- -2.35
- rvis_percentile_EVS
- 1.14
Haploinsufficiency Scores
- pHI
- 0.380
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.623
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.858
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cit
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype;
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;mitotic cell cycle;mitotic cytokinesis;protein phosphorylation;Golgi organization;regulation of actin polymerization or depolymerization;positive regulation of cytokinesis;intracellular signal transduction;generation of neurons;neuron apoptotic process
- Cellular component
- cytosol;membrane;midbody;Golgi cisterna;cleavage furrow;neuronal cell body
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;Rho GTPase binding;SH3 domain binding;PDZ domain binding;metal ion binding;scaffold protein binding